 |
PDBsum entry 5fob
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Lipid binding protein
|
PDB id
|
|
|
|
5fob
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
642 a.a.
|
 |
|
|
|
|
|
|
|
902 a.a.
|
 |
|
|
|
|
|
|
|
240 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lipid binding protein
|
 |
|
Title:
|
 |
Crystal structure of human complement c3b in complex with smallpox inhibitor of complement (spice)
|
|
Structure:
|
 |
Complement c3 beta chain. Chain: a. Fragment: residues 23-667. Synonym: c3 and pzp-like alpha-2-macroglobulin domain-containing protein 1. Complement c3b alpha' chain. Chain: b. Fragment: ccp domains, residues 749-1663. Smallpox inhibitor of complement spice, d15l.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Other_details: purified from human plasma. Variola major virus. Organism_taxid: 12870. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.199
|
R-free:
|
0.230
|
|
|
Authors:
|
 |
F.Forneris,J.Wu,X.Xue,P.Gros
|
|
Key ref:
|
 |
F.Forneris
et al.
(2016).
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.
Embo J,
35,
1133-1149.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
18-Nov-15
|
Release date:
|
06-Apr-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01024
(CO3_HUMAN) -
Complement C3 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1663 a.a.
642 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Embo J
35:1133-1149
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.
|
|
F.Forneris,
J.Wu,
X.Xue,
D.Ricklin,
Z.Lin,
G.Sfyroera,
A.Tzekou,
E.Volokhina,
J.C.Granneman,
R.Hauhart,
P.Bertram,
M.K.Liszewski,
J.P.Atkinson,
J.D.Lambris,
P.Gros.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Regulators of complement activation (RCA) inhibit complement-induced immune
responses on healthy host tissues. We present crystal structures of human RCA
(MCP, DAF, and CR1) and a smallpox virus homolog (SPICE) bound to complement
component C3b. Our structural data reveal that up to four consecutive homologous
CCP domains (i-iv), responsible for inhibition, bind in the same orientation and
extended arrangement at a shared binding platform on C3b. Large sequence
variations in CCP domains explain the diverse C3b-binding patterns, with limited
or no contribution of some individual domains, while all regulators show
extensive contacts with C3b for the domains at the third site. A variation
of ~100° rotation around the longitudinal axis is observed for domains
binding at the fourth site on C3b, without affecting the overall binding mode.
The data suggest a common evolutionary origin for both inhibitory mechanisms,
called decay acceleration and cofactor activity, with variable C3b binding
through domains at sites ii, iii, and iv, and provide a framework for
understanding RCA disease-related mutations and immune evasion.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |